Merck, Plaintiffs Bicker Over Fosamax MDL Wind-Down Plans
Merck & Co. Inc. and the plaintiffs suing the company over jaw injuries allegedly caused by the bone drug Fosamax proposed competing plans for the wind-down of multidistrict litigation on Monday,...To view the full article, register now.
Already a subscriber? Click here to view full article